Altogether, these results show that exclusive or higher CCRL2 expression in tumor cells relative to the host concentrates chemerin locally and inhibits tumor neoangiogenesis, with consequences similar to those resulting from the expression of bioactive chemerin by tumor cells or by the host. This evidence concerns the gene CCRL2 and neoplasm.